sur CARMAT (EPA:ALCAR)
Update on CARMAT's judicial recovery
CARMAT, a specialist in artificial hearts, has announced an update on its receivership proceedings. These proceedings were initiated on July 1, 2025. A takeover bid submitted by HOUGOU was rejected by the Versailles Court due to the failure to lift the conditions precedent. Consequently, a petition for conversion into compulsory liquidation has been filed.
The court postponed its decision until November 25, 2025, leaving until November 3, 2025, for the submission of new proposals. CARMAT warns that without new offers, compulsory liquidation is likely, with heavy losses for shareholders and creditors.
In this context, the company remains focused on supporting the wearers of its artificial heart, Aeson®. Trading in CARMAT shares remains suspended until further notice.
R. P.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de CARMAT